Standard BioTools
LAB
LAB
146 hedge funds and large institutions have $308M invested in Standard BioTools in 2025 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 39 increasing their positions, 42 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
37% less capital invested
Capital invested by funds: $487M → $308M (-$179M)
90% less call options, than puts
Call options by funds: $6K | Put options by funds: $62K
Holders
146
Holding in Top 10
2
Calls
$6K
Puts
$62K
Top Buyers
| 1 | +$7.24M | |
| 2 | +$5.21M | |
| 3 | +$3.68M | |
| 4 |
MCO
MAK Capital One
New York
|
+$3M |
| 5 |
PCP
Pacific Capital Partners
London,
|
+$621K |
Top Sellers
| 1 | -$6.63M | |
| 2 | -$3.73M | |
| 3 | -$2.17M | |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
-$701K |
| 5 |
Goldman Sachs
New York
|
-$537K |